To analyse brain cancer patterns in Canada, particularly according to age and sex distributions, temporal patterns and regional variations. Changes in diagnostic techniques, survival rates and trends by tumour type were also examined.
Descriptive epidemiologic study based on Canada-wide population data for 1959-88.
Rates of death, incidence and admission to hospital because of brain cancer, as well as survival time and methods of diagnosis.
Incidence and death rates and time trends were examined for Canada as a whole, by province and by census division.
The rates of death from brain cancer increased rapidly among Canadians aged 55 years or more from 1959 to 1988. In particular, age-adjusted death rates increased by 117%, 797% and 118% among men 65 to 74 years, 75 to 84 and 85 or more respectively. The corresponding increases among women were 138%, 535% and 400%. The incidence rates also increased substantially. The trends in incidence rates by tumour type indicated that the increase was more pronounced for glioblastomas. The incidence rates of cases detected histologically, radiologically and clinically all increased.
Because glioblastomas are generally easier to diagnose than astrocytomas and because the incidence rates of glioblastomas were found to increase substantially, the increased brain cancer rates among elderly people may not be entirely attributable to improved diagnostic techniques. However, analytic investigations of the impact of changes in diagnostic procedures on brain cancer trends are needed to clarify this issue.
Notes
Cites: Natl Cancer Inst Monogr. 1961 Sep;6:101-2113889176
Cites: J Natl Cancer Inst. 1990 Oct 17;82(20):1621-42213902
Cites: Am J Epidemiol. 1988 Oct;128(4):778-853421243
Cites: J Natl Cancer Inst. 1987 Apr;78(4):601-93104645
Cites: Tumori. 1988 Jun 30;74(3):243-522840762
Cites: Lancet. 1989 Nov 25;2(8674):1272-32573778
Cites: Neuroepidemiology. 1989;8(6):283-952586698
Cites: Lancet. 1988 Mar 19;1(8586):633-62894559
Cites: APMIS. 1988 Dec;96(12):1066-743214581
Cites: Int J Epidemiol. 1988 Mar;17(1):33-83384546
Cites: J Natl Cancer Inst. 1987 Aug;79(2):233-83474455
Cites: Toxicol Ind Health. 1986 Jul;2(1):127-443787641
Cites: Am J Epidemiol. 1986 Aug;124(2):334-73728449
Cites: Tumori. 1985 Jun 30;71(3):201-184024279
Cites: Lancet. 1990 Aug 25;336(8713):474-811974997
Cites: Am J Public Health. 1990 Feb;80(2):169-722297060
Cites: J Natl Cancer Inst. 1983 Jan;70(1):75-816571925
Cites: J Natl Cancer Inst. 1981 Jun;66(6):1191-3087017215
Cites: Ann N Y Acad Sci. 1982;381:6-166953802
Cites: Am J Epidemiol. 1982 Nov;116(5):782-907148804
Cites: Am J Epidemiol. 1979 Mar;109(3):309-19453168
Cites: Am J Epidemiol. 1976 Nov;104(5):499-510984024